Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Retained Earnings (2020 - 2026)

Invivyd's (IVVD) quarterly Retained Earnings came in at -$1.0 billion in Q2 2026, down 11.51% on a YoY basis from -$1.2 billion in Q2 2025, and down 8.99% quarter-over-quarter from -$954.5 million in Q4 2025.

Analysis

Invivyd (IVVD) Retained Earnings (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Retained Earnings for 7 consecutive years, with -$1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings fell 11.51% year-over-year to -$1.0 billion; the trailing twelve-month figure through Jun 2026 stood at -$1.0 billion (down 11.51% YoY), and the FY2025 full-year result was -$954.5 million, down 5.82% from the prior year.
  • Retained Earnings retreated to -$1.0 billion in Q2 2026 per IVVD's latest filing, from -$954.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$392.8 million in Q1 2022 and bottomed at -$1.0 billion in Q2 2026.
  • Historically, Retained Earnings has averaged -$741.8 million across 5 years, with a median of -$775.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings tumbled 198.45% in 2022, then fell 5.82% in 2025.
  • Over 5 years, Retained Earnings stood at -$533.4 million in 2022, then plunged by 37.24% to -$732.1 million in 2023, then decreased by 23.21% to -$902.0 million in 2024, then decreased by 5.82% to -$954.5 million in 2025, then retreated by 8.99% to -$1.0 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$1.0 billion, -$954.5 million, and -$943.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.04 Bn
Dec 31, 2025 -954.48 Mn
Sep 30, 2025 -943.41 Mn
Jun 30, 2025 -932.94 Mn
Mar 31, 2025 -918.30 Mn
Dec 31, 2024 -901.99 Mn
Sep 30, 2024 -883.60 Mn
Jun 30, 2024 -822.81 Mn
Mar 31, 2024 -775.60 Mn
Dec 31, 2023 -732.07 Mn
Sep 30, 2023 -658.42 Mn
Jun 30, 2023 -619.00 Mn
Mar 31, 2023 -568.75 Mn
Dec 31, 2022 -533.43 Mn
Sep 30, 2022 -488.90 Mn
Jun 30, 2022 -443.80 Mn
Mar 31, 2022 -392.80 Mn
Dec 31, 2021 -292.11 Mn
Sep 30, 2021 -209.10 Mn
Jun 30, 2021 -148.70 Mn